These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

492 related items for PubMed ID: 9051296

  • 1. Aminoguanidine--effects on endoneurial vasoactive nitric oxide and on motor nerve conduction velocity in control and streptozotocin-diabetic rats.
    Dewhurst M, Omawari N, Tomlinson DR.
    Br J Pharmacol; 1997 Feb; 120(4):593-8. PubMed ID: 9051296
    [Abstract] [Full Text] [Related]

  • 2. Reduced nerve blood flow in diabetic rats: relationship to nitric oxide production and inhibition of aldose reductase.
    Tomlinson DR, Dewhurst M, Stevens EJ, Omawari N, Carrington AL, Vo PA.
    Diabet Med; 1998 Jul; 15(7):579-85. PubMed ID: 9686698
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Deficient nitric oxide responsible for reduced nerve blood flow in diabetic rats: effects of L-NAME, L-arginine, sodium nitroprusside and evening primrose oil.
    Omawari N, Dewhurst M, Vo P, Mahmood S, Stevens E, Tomlinson DR.
    Br J Pharmacol; 1996 May; 118(1):186-90. PubMed ID: 8733594
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Depletion of nitric oxide synthase-containing neurons in the diabetic retina: reversal by aminoguanidine.
    Roufail E, Soulis T, Boel E, Cooper ME, Rees S.
    Diabetologia; 1998 Dec; 41(12):1419-25. PubMed ID: 9867208
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Experiments with nitric oxide synthase inhibitors in spinal nerve ligated rats provide no evidence of a role for nitric oxide in neuropathic mechanical allodynia.
    Lee DH, Singh JP, Lodge D.
    Neurosci Lett; 2005 Sep 16; 385(3):179-83. PubMed ID: 15964141
    [Abstract] [Full Text] [Related]

  • 9. An analysis of renal nitric oxide contribution to hyperfiltration in diabetic rats.
    Schwartz D, Schwartz IF, Blantz RC.
    J Lab Clin Med; 2001 Feb 16; 137(2):107-14. PubMed ID: 11174467
    [Abstract] [Full Text] [Related]

  • 10. Chronic administration of aminoguanidine reduces vascular nitric oxide production and attenuates liver damage in bile duct-ligated rats.
    Wei CL, Hon WM, Lee KH, Khoo HE.
    Liver Int; 2005 Jun 16; 25(3):647-56. PubMed ID: 15910502
    [Abstract] [Full Text] [Related]

  • 11. Correction of nerve conduction and endoneurial blood flow deficits by the aldose reductase inhibitor, tolrestat, in diabetic rats.
    Cotter MA, Cameron NE, Hohman TC.
    J Peripher Nerv Syst; 1998 Jun 16; 3(3):217-23. PubMed ID: 10959252
    [Abstract] [Full Text] [Related]

  • 12. Neurovascular effects of L-carnitine treatment in diabetic rats.
    Cameron NE, Cotter MA.
    Eur J Pharmacol; 1997 Jan 29; 319(2-3):239-44. PubMed ID: 9042596
    [Abstract] [Full Text] [Related]

  • 13. Pioglitazone, a PPARgamma agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats.
    Majithiya JB, Paramar AN, Balaraman R.
    Cardiovasc Res; 2005 Apr 01; 66(1):150-61. PubMed ID: 15769458
    [Abstract] [Full Text] [Related]

  • 14. Effect of nitric oxide synthase inhibitor on optic nerve head circulation in conscious rabbits.
    Sugiyama T, Oku H, Ikari S, Ikeda T.
    Invest Ophthalmol Vis Sci; 2000 Apr 01; 41(5):1149-52. PubMed ID: 10752953
    [Abstract] [Full Text] [Related]

  • 15. The protective effect of NG-nitro-L-arginine methyl ester and insulin on nitric oxide inhibition and pathology in experimental diabetic rat liver.
    Ozden H, Tekin N, Akyuz F, Gurer F, Ustuner MC, Kucuk F, Guven G, Yaylak F.
    Saudi Med J; 2009 Jan 01; 30(1):30-4. PubMed ID: 19139769
    [Abstract] [Full Text] [Related]

  • 16. Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rats.
    Soulis T, Cooper ME, Sastra S, Thallas V, Panagiotopoulos S, Bjerrum OJ, Jerums G.
    Diabetologia; 1997 Oct 01; 40(10):1141-51. PubMed ID: 9349594
    [Abstract] [Full Text] [Related]

  • 17. L-arginine and antioxidant diet supplementation partially restores nitric oxide-dependent regulation of phenylephrine renal vasoconstriction in diabetics rats.
    Coronel I, Arellano-Mendoza MG, del Valle-Mondragon L, Vargas-Robles H, Castorena-Torres F, Romo E, Rios A, Escalante B.
    J Ren Nutr; 2010 May 01; 20(3):158-68. PubMed ID: 20097580
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of nitric oxide synthase by L-NAME improves ventricular performance in streptozotocin-diabetic rats.
    Smith JM, Paulson DJ, Romano FD.
    J Mol Cell Cardiol; 1997 Sep 01; 29(9):2393-402. PubMed ID: 9299363
    [Abstract] [Full Text] [Related]

  • 19. Decrease in cochlear blood flow with infusion of nitric oxide synthase inhibitor and its recovery with L-arginine infusion: comparison with abdominal blood flow and auricular blood flow.
    Hoshijima H, Makimoto K.
    Acta Otolaryngol; 2002 Dec 01; 122(8):808-15. PubMed ID: 12542197
    [Abstract] [Full Text] [Related]

  • 20. Effect of orchiectomy on renal function in control and diabetic rats with chronic inhibition of nitric oxide.
    Anderson S, Chapman JG, Oyama TT, Komers R.
    Clin Exp Pharmacol Physiol; 2010 Jan 01; 37(1):19-23. PubMed ID: 19473197
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.